Cargando…
PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429015/ http://dx.doi.org/10.1097/01.HS9.0000850136.22948.60 |
| _version_ | 1784779300301438976 |
|---|---|
| author | Gao, X.-N. Lou, X. Lin, J. Su, Y.-F. Wang, J. Xu, L. Yu, H. Wang, A. Wang, Y.-Z. Liu, D.-H. |
| author_facet | Gao, X.-N. Lou, X. Lin, J. Su, Y.-F. Wang, J. Xu, L. Yu, H. Wang, A. Wang, Y.-Z. Liu, D.-H. |
| author_sort | Gao, X.-N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290152022-08-31 PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES Gao, X.-N. Lou, X. Lin, J. Su, Y.-F. Wang, J. Xu, L. Yu, H. Wang, A. Wang, Y.-Z. Liu, D.-H. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429015/ http://dx.doi.org/10.1097/01.HS9.0000850136.22948.60 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Gao, X.-N. Lou, X. Lin, J. Su, Y.-F. Wang, J. Xu, L. Yu, H. Wang, A. Wang, Y.-Z. Liu, D.-H. PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title | PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title_full | PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title_fullStr | PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title_full_unstemmed | PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title_short | PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES |
| title_sort | pb1821: combination of bcl-2 inhibitor, hypomethylation agents and low-dose cytarabine as a salvage therapy for acute myeloid leukemia and myelodysplastic syndromes |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429015/ http://dx.doi.org/10.1097/01.HS9.0000850136.22948.60 |
| work_keys_str_mv | AT gaoxn pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT loux pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT linj pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT suyf pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT wangj pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT xul pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT yuh pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT wanga pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT wangyz pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes AT liudh pb1821combinationofbcl2inhibitorhypomethylationagentsandlowdosecytarabineasasalvagetherapyforacutemyeloidleukemiaandmyelodysplasticsyndromes |